sk&f-38393 has been researched along with devazepide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frydryszak, H; Stoessl, AJ; Van Kampen, J | 1 |
| Aja, SM; Barrett, JA; Chan, P; Gietzen, DW | 1 |
2 other study(ies) available for sk&f-38393 and devazepide
| Article | Year |
|---|---|
Behavioural evidence for cholecystokinin-dopamine D1 receptor interactions in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzodiazepinones; Cholecystokinin; Devazepide; Grooming; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1996 |
DA1 receptor activity opposes anorectic responses to amino acid-imbalanced diets.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amino Acids; Animals; Benzazepines; Devazepide; Diet; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Feeding Behavior; Indoles; Male; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin Antagonists; Tropisetron | 1999 |